Minor Histocompatibility Antigen-Specific T Cells

Minor Histocompatibility Antigen-Specific T Cells

Minor Histocompatibility (H) antigens are major histocompatibility complex (MHC)/Human Leukocyte Antigen (HLA)-bound peptides that differ between allogeneic hematopoietic stem cell transplantation (HCT) recipients and their donors as a result of genetic polymorphisms. Some minor H antigens can be us...

Full description

Bibliographic Details
Main Authors:	Corinne Summers, Vipul S. Sheth, Marie Bleakley
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2020-06-01
Series:	Frontiers in Pediatrics
Subjects:	minor histocompatibility antigen T cell immunotherapy hematopoietic stem cell transplantation leukemia pediatric graft-vs.-leukemia
Online Access:	https://www.frontiersin.org/article/10.3389/fped.2020.00284/full

Similar Items

Discovery and Differential Processing of HLA Class II-Restricted Minor Histocompatibility Antigen LB-PIP4K2A-1S and Its Allelic Variant by Asparagine Endopeptidase
by: Anita N. Kremer, et al.
Published: (2020-03-01)

Minor histocompatibility antigens HA‐8 and PANE1 in the TUNISIAN population
by: Rahma Said, et al.
Published: (2022-11-01)

Comparative analysis of minor histocompatibility antigens genotyping methods
by: A. S. Vdovin, et al.
Published: (2016-08-01)

Autosomal minor histocompatibility antigens; How genetic variants create diversity in immune targets
by: Marieke eGriffioen, et al.
Published: (2016-03-01)

H60: A Unique Murine Hematopoietic Cell-Restricted Minor Histocompatibility Antigen for Graft-versus-Leukemia Effect
by: Eun Young Choi, et al.
Published: (2020-06-01)

Enhancement of Antigen Presentation by Deletion of Viral Immune Evasion Genes Prevents Lethal Cytomegalovirus Disease in Minor Histocompatibility Antigen-Mismatched Hematopoietic Cell Transplantation
by: Emin Gezinir, et al.
Published: (2020-06-01)

Single step multiple genotyping by MALDI-TOF mass spectrometry, for evaluation of minor histocompatibility antigens in patients submitted to allogeneic stem cell transplantation from HLA-matched related and unrelated donor
by: Federica Cattina, et al.
Published: (2017-09-01)

Optimized Whole Genome Association Scanning for Discovery of HLA Class I-Restricted Minor Histocompatibility Antigens
by: Kyra J. Fuchs, et al.
Published: (2020-04-01)

Does minor histocompatibility antigen HA-1 disparity affect the occurrence of graft-versus-host disease in tunisian recipients of hematopoietic stem cells?
by: Mohamed Hichem Sellami, et al.
Published: (2010-01-01)

CD4 Donor Lymphocyte Infusion Can Cause Conversion of Chimerism Without GVHD by Inducing Immune Responses Targeting Minor Histocompatibility Antigens in HLA Class II
by: Peter van Balen, et al.
Published: (2018-12-01)

Improved survival outcomes and restoration of graft‐vs‐leukemia effect by deferasirox after allogeneic stem cell transplantation in acute myeloid leukemia
by: Byung‐Sik Cho, et al.
Published: (2019-02-01)

Editorial: Cellular Therapies: Past, Present and Future
by: Ralf Dressel, et al.
Published: (2018-08-01)

HA-1H T-Cell Receptor Gene Transfer to Redirect Virus-Specific T Cells for Treatment of Hematological Malignancies After Allogeneic Stem Cell Transplantation: A Phase 1 Clinical Study
by: Peter van Balen, et al.
Published: (2020-08-01)

Umbilical cord blood transplantation: Still growing and improving
by: Xiaoyu Zhu, et al.
Published: (2021-11-01)

Cutaneous graft-versus-host disease after hematopoietic stem cell transplant - a review
by: Cesar Daniel Villarreal Villarreal, et al.
Published: (2016-06-01)

Importance of killer immunoglobulin-like receptors in allogeneic hematopoietic stem cell transplantation
by: Danilo Santana Alessio Franceschi, et al.
Published: (2011-01-01)

Immunology of cord blood T-cells favors augmented disease response during clinical pediatric stem cell transplantation for acute leukemia
by: Roisin Borrill, et al.
Published: (2023-09-01)

Immune reconstitution and graft-versus-host reactions in rat models of allogeneic hematopoietic cell transplantation
by: Severin eZinöcker, et al.
Published: (2012-11-01)

Bone Marrow Transplantation 1957-2019
by: Elizabeth Simpson, et al.
Published: (2019-06-01)

T-Cell Immunotherapies Targeting Histocompatibility and Tumor Antigens in Hematological Malignancies
by: Valérie Janelle, et al.
Published: (2020-02-01)

Spectral flow cytometry cluster analysis of therapeutic donor lymphocyte infusions identifies T cell subsets associated with outcome in patients with AML relapse
by: Ivan Odak, et al.
Published: (2022-10-01)

Association of human leukocyte antigen with precursor-B acute lymphoblastic leukaemia (pre-B ALL) in Malays
by: Hassan, Norfarazieda
Published: (2013)

Editorial: Advances in Pediatric Hematopoietic Cell Therapies and Transplantation
by: Emmanuel Katsanis, et al.
Published: (2022-01-01)

Optimizing Transplant Approaches and Post-Transplant Strategies for Patients With Acute Myeloid Leukemia
by: Justin Loke, et al.
Published: (2021-04-01)

A case of psoriasiform graft-versus-host disease
by: Jinping HUANG, et al.
Published: (2022-06-01)

Acute myeloid leukemia in SRP54‐mutated congenital neutropenia
by: Anthony Sabulski, et al.
Published: (2022-05-01)

The Graft-Versus-Leukemia Effect in AML
by: Connor Sweeney, et al.
Published: (2019-11-01)

Brazilian workshop model to train investigators in chronic graft-versus-host disease clinical trials according to the 2005-2006 National Institutes of Health recommendations
by: Rita de Cássia Barbosa da Silva Tavares, et al.
Published: (2011-10-01)

Mouse Models of Antigen Presentation in Hematopoietic Stem Cell Transplantation
by: Motoko Koyama, et al.
Published: (2021-09-01)

Health-care utilization and outcomes of patients at high risk of invasive fungal infection
by: Fu R, et al.
Published: (2018-07-01)

Allogeneic Hematopoietic Stem Cell Transplantation for Children With Acute Lymphoblastic Leukemia: Shifting Indications in the Era of Immunotherapy
by: Tony H. Truong, et al.
Published: (2021-12-01)

Donor-Derived CD123-Targeted CAR T Cell Serves as a RIC Regimen for Haploidentical Transplantation in a Patient With FUS-ERG+ AML
by: Sun Yao, et al.
Published: (2019-12-01)

Mesenchymal stem cell-derived exosomes can alleviate GVHD and preserve the GVL effect in allogeneic stem cell transplantation animal models
by: Yan Jiang, et al.
Published: (2023-12-01)

Frequency of Major Histocompatibility Antigens Class I in Mazandaran Province
by: Fatemeh Toghani Hulari, et al.
Published: (2022-04-01)

The Role of Co-stimulatory/Co-inhibitory Signals in Graft-vs.-Host Disease
by: Sandeep Kumar, et al.
Published: (2018-12-01)

Hematopoietic Stem Cell Transplantation—50 Years of Evolution and Future Perspectives
by: Israel Henig, et al.
Published: (2014-10-01)

Computational Analysis of HLA-presentation of Non-synonymous Recipient Mismatches Indicates Effect on the Risk of Chronic Graft-vs.-Host Disease After Allogeneic HSCT
by: Jarmo Ritari, et al.
Published: (2019-07-01)

Donor cell‐derived chronic myelomonocytic leukemia presenting after allogeneic hematopoietic cell transplantation for T‐cell acute lymphoblastic leukemia
by: Kevin C. Miller, et al.
Published: (2020-12-01)

The Evolution of T Cell Depleted Haploidentical Transplantation
by: Franco Aversa, et al.
Published: (2019-11-01)

The role of KIR genes and ligands in leukemia surveillance
by: Florian eBabor, et al.
Published: (2013-02-01)